Skip to main content

Table 2 Behcet’s disease patients' Characteristics

From: The association between vitamin D levels and oxidative stress markers in Egyptian Behcet’s disease patients

Parameter

BD patients (N = 60)

Disease duration (years)a

9.55 ± 6.60

BDCAFa

5.18 ± 3.59

Severity Scorea

3.06 ± 2.9

Clinical involvement b

N0 (%)

 Oral ulcers

55 ( 91.66)

 Genital ulcers

51 (85)

 Pseudofolliculitis/Erythema nodosum

13 (21.66)

 Articular involvement

8(13.33)

 Ocular involvement

38(63.33)

 Neurological involvement

20(33.33)

 Vascular involvement

35(58.33)

Current Medicationsb

N0 (%)

 CorticoSteroids > 10 mg/day

36 (60)

 Azathioprine

19(31.66)

 Colchicine

24(40)

 Cyclosporine

9(15)

 Cyclophosphamide

8(13.33)

 Methotrexate

9(15)

 Infliximab

15(25)

  1. BDCAF Behcet's Disease current Activity form
  2. aContinuous variables: mean ± SD
  3. bcategorical variables: number (%)